Standout Papers

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing ut... 1994 2026 2004 2015 504
  1. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. (1994)
    Larry J. Black, Masahiko Sato et al. Journal of Clinical Investigation

Immediate Impact

1 by Nobel laureates 39 from Science/Nature 77 standout
Sub-graph 1 of 21

Citing Papers

Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020 Standout
Coupling of bone resorption and formation by RANKL reverse signalling
2018 StandoutNature
2 intermediate papers

Works of David E. Magee being referenced

Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene
1997
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
1994 Standout

Author Peers

Author Last Decade Papers Cites
David E. Magee 874 339 356 17 1.3k
Larry J. Black 1042 376 328 16 1.4k
Ellen R. Rowley 702 253 291 10 1.0k
George J. Cullinan 713 286 415 14 1.4k
Lorri L. Short 510 115 245 18 994
Richard J. Hershcopf 704 508 357 20 1.6k
William R. Bensch 477 345 636 18 1.5k
Ben P. Haynes 1065 184 304 32 1.5k
G. Ornati 934 206 291 22 1.2k
S. Nilsson 507 191 373 16 1.0k
Carmen J. Narvaez 548 155 460 29 1.6k

All Works

Loading papers...

Rankless by CCL
2026